| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(91)90560-L |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:009286749190560L?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:009286749190560L?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1646078 |
| P50 | author | Bert Vogelstein | Q827502 |
| Jill Bargonetti | Q91042227 | ||
| P2093 | author name string | C. Prives | |
| S. E. Kern | |||
| P. N. Friedman | |||
| P2860 | cites work | Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein | Q42215813 |
| Specific interaction between the p53 cellular tumour antigen and major heat shock proteins | Q43512047 | ||
| Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. | Q43554604 | ||
| Association of human papillomavirus types 16 and 18 E6 proteins with p53. | Q43701619 | ||
| p53 and DNA polymerase alpha compete for binding to SV40 T antigen | Q44581576 | ||
| The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence | Q45233544 | ||
| Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus | Q45828140 | ||
| The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen | Q46840212 | ||
| Mouse p53 inhibits SV40 origin-dependent DNA replication | Q46905586 | ||
| Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. | Q53505779 | ||
| Trans-complementable copy-number mutants of plasmid ColE1. | Q54559090 | ||
| Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells | Q64381309 | ||
| Mutant p53 proteins bind DNA abnormally in vitro | Q67912813 | ||
| Transcription factor LSF binds two variant bipartite sites within the SV40 late promoter | Q68459469 | ||
| A 100-kD HeLa cell octamer binding protein (OBP100) interacts differently with two separate octamer-related sequences within the SV40 enhancer | Q69816471 | ||
| Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene | Q24298218 | ||
| 57 Sequencing end-labeled DNA with base-specific chemical cleavages | Q27860479 | ||
| Mutations in the p53 gene occur in diverse human tumour types | Q28249770 | ||
| Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas | Q28269089 | ||
| Identification of p53 as a sequence-specific DNA-binding protein | Q28282745 | ||
| Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain | Q28295806 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Suppression of human colorectal carcinoma cell growth by wild-type p53 | Q29618318 | ||
| T antigen is bound to a host protein in SY40-transformed cells | Q29618321 | ||
| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
| The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter | Q29620405 | ||
| Wild-type p53 can inhibit oncogene-mediated focus formation | Q30450825 | ||
| Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen | Q33913536 | ||
| P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts | Q33933630 | ||
| Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen | Q34163571 | ||
| Monoclonal antibodies specific for simian virus 40 tumor antigens | Q34249232 | ||
| p53 functions as a cell cycle control protein in osteosarcomas | Q34254691 | ||
| The p53 proto-oncogene can act as a suppressor of transformation | Q34440370 | ||
| p53: oncogene or anti-oncogene? | Q34627381 | ||
| Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells | Q35235746 | ||
| The p53 complex from monkey cells modulates the biochemical activities of simian virus 40 large T antigen | Q36781766 | ||
| Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life | Q36782441 | ||
| Expression and complex formation of simian virus 40 large T antigen and mouse p53 in insect cells | Q36872197 | ||
| Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines | Q36919740 | ||
| Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products | Q37855080 | ||
| The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses | Q37855772 | ||
| Structural aspects of the p53 protein in relation to gene evolution | Q37856166 | ||
| Binding and unwinding--how T antigen engages the SV40 origin of DNA replication | Q37870911 | ||
| When the products of oncogenes and anti-oncogenes meet | Q38596880 | ||
| Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses | Q39645341 | ||
| Monoclonal antibody analysis of p53 expression in normal and transformed cells | Q40127251 | ||
| Oligomerization of oncoprotein p53. | Q40129645 | ||
| Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells | Q40237209 | ||
| Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53. | Q40461080 | ||
| Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport | Q41694667 | ||
| Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein | Q41696617 | ||
| Genetic mechanisms of tumor suppression by the human p53 gene | Q41710706 | ||
| Presence of a potent transcription activating sequence in the p53 protein | Q41724404 | ||
| Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome | Q41816411 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA replication | Q130996 |
| regulatory sequence | Q3238407 | ||
| viral replication | Q114773374 | ||
| P304 | page(s) | 1083-1091 | |
| P577 | publication date | 1991-06-01 | |
| 1991-06-14 | |||
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication | |
| P478 | volume | 65 |
| Q35937193 | A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18 |
| Q33935234 | A cis-acting DNA signal for encapsidation of simian virus 40 |
| Q36676609 | A mitogen-responsive promoter region that is synergistically activated through multiple signalling pathways |
| Q40655196 | A transcriptionally active DNA-binding site for human p53 protein complexes |
| Q53469260 | Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma. |
| Q36648425 | Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway |
| Q40408305 | Activation of the cryptic DNA binding function of mutant forms of p53. |
| Q40037740 | Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. |
| Q33964757 | Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF. |
| Q40524547 | Advances in cancer gene therapy |
| Q41227408 | Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group |
| Q36560030 | Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein |
| Q40064310 | Altered phosphorylation of free and bound forms of monkey p53 and simian virus 40 large T antigen during lytic infection |
| Q40021667 | Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids |
| Q33292314 | Analysis of a protein-binding domain of p53 |
| Q36822360 | Analysis of a replication initiation sequence from the adenosine deaminase region of the mouse genome |
| Q37286062 | Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations |
| Q40944245 | Antisense oncogene and tumor suppressor gene therapy of cancer |
| Q28611432 | Apoptosis, cancer and the p53 tumour suppressor gene |
| Q38345165 | Architectural accommodation in the complex of four p53 DNA binding domain peptides with the p21/waf1/cip1 DNA response element |
| Q35881315 | Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays. |
| Q29615610 | Cancer. p53, guardian of the genome |
| Q60065869 | Cell checkpoint and radiosensitivity |
| Q30860353 | Cell-specific modulation of papovavirus replication by tumor suppressor protein p53 |
| Q40241358 | Chromosome loss, hyperrecombination, and cell cycle arrest in a yeast mcm1 mutant |
| Q40021927 | Complex formation between p53 and replication protein A inhibits the sequence-specific DNA binding of p53 and is regulated by single-stranded DNA |
| Q38313400 | Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. |
| Q27730393 | Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms |
| Q36510188 | Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation |
| Q38345163 | DNA bending is essential for the site-specific recognition of DNA response elements by the DNA binding domain of the tumor suppressor protein p53. |
| Q28207794 | Definition of a consensus binding site for p53 |
| Q35871078 | Differential interaction of temperature-sensitive simian virus 40 T antigens with tumor suppressors pRb and p53 |
| Q77844569 | Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery |
| Q40017199 | Discrimination of DNA Binding Sites by Mutant p53 Proteins |
| Q42072409 | Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2. |
| Q91964954 | Do Mutations Turn p53 into an Oncogene? |
| Q41731875 | Drosophila p53 binds a damage response element at the reaper locus |
| Q34959692 | Drosophila p53 preserves genomic stability by regulating cell death |
| Q34684950 | E2 ligase dRad6 regulates DMP53 turnover in Drosophila |
| Q41128839 | EGF effects on p53 in MDA-468 human breast cancer cells: implications for G1 arrest |
| Q33937821 | Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest |
| Q48881553 | Expression of p185 and p53 in benign and malignant colorectal lesions |
| Q24633970 | FinO is an RNA chaperone that facilitates sense-antisense RNA interactions |
| Q36648185 | Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency |
| Q36637002 | Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression |
| Q41557652 | Gain of function mutations in p53. |
| Q91710103 | Gain-of-function mutant p53: history and speculation |
| Q24791259 | Glycerol restores heat-induced p53-dependent apoptosis of human glioblastoma cells bearing mutant p53 |
| Q38306067 | Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53. |
| Q36620279 | Growth dysregulation and p53 accumulation in human primary colorectal cancer |
| Q41632284 | Growth inhibition by anchorage-deficiency is associated with increased level but reduced phosphorylation of mutant p53 |
| Q40535811 | Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner |
| Q30450287 | Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. |
| Q40678382 | Human p53 inhibits growth in Schizosaccharomyces pombe |
| Q40406039 | Identification of a DNA structural motif that includes the binding sites for Sp1, p53 and GA-binding protein |
| Q36706865 | Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding |
| Q47916460 | Identification of a unique form of p53 in human cord blood associated with the development of maternal autoantibodies |
| Q33877751 | Identification of two novel functional p53 responsive elements in the herpes simplex virus-1 genome |
| Q37013182 | Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. |
| Q68099205 | Inhibition of DNA synthesis by TGF-beta 1 coincides with inhibition of phosphorylation and cytoplasmic translocation of p53 protein |
| Q36564894 | Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor |
| Q24317013 | Inhibition of p53 DNA binding by human papillomavirus E6 proteins |
| Q40066650 | Inhibition of viral and cellular promoters by human wild-type p53 |
| Q28639970 | Interaction of p53 with its consensus DNA-binding site |
| Q42818894 | Intermolecular phosphorylation between insulin holoreceptors does not stimulate substrate kinase activity |
| Q42120899 | Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein |
| Q47791939 | Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression |
| Q73223983 | Low Grade Amplification of MDM2 Gene in a Subset of Human Breast Cancers without p53 Alterations |
| Q99240174 | MDM2-C Functions as an E3 Ubiquitin Ligase |
| Q40421511 | Mammalian p53 can function as a transcription factor in yeast |
| Q36273391 | Mechanisms and markers of carcinogenesis and neoplastic progression |
| Q29615657 | Modes of p53 regulation |
| Q40281014 | Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells |
| Q42410745 | Molecular dynamics simulations of p53 DNA-binding domain |
| Q28565834 | Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene |
| Q42071650 | Murine p53 inhibits the function but not the formation of SV40 T antigen hexamers and stimulates T antigen RNA helicase activity |
| Q36920336 | Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1 |
| Q36695883 | Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage |
| Q33961348 | Mutation in the bimD gene of Aspergillus nidulans confers a conditional mitotic block and sensitivity to DNA damaging agents |
| Q41783753 | Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma |
| Q37049477 | Negative regulation of Rb expression by the p53 gene product |
| Q42078862 | Neuregulin 1-Beta cytoprotective role in AML 12 mouse hepatocytes exposed to pentachlorophenol |
| Q36485499 | Non-p53 p53RE binding protein, a human transcription factor functionally analogous to P53. |
| Q38045766 | Overexpression of p53 protein in human tumors |
| Q37058260 | Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I |
| Q53475443 | P53 accumulation in precursor lesions and early stages of bladder cancer. |
| Q28611435 | P53, cell cycle control and apoptosis: Implications for cancer |
| Q33600943 | Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase. |
| Q77759417 | Poly ADP-ribosylation: a DNA break signal mechanism |
| Q28269174 | Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions |
| Q35691217 | Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer |
| Q35070008 | Polyomavirus T antigens activate an antiviral state |
| Q47588075 | Preferred drifting along the DNA major groove and cooperative anchoring of the p53 core domain: mechanisms and scenarios |
| Q38931100 | Proteasome inhibitors suppress the protein expression of mutant p53. |
| Q36568304 | Proteolysis by calpains: a possible contribution to degradation of p53. |
| Q35212701 | Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4. |
| Q74355214 | RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome |
| Q41172543 | Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis |
| Q35208579 | Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. |
| Q38352373 | Regulation of mutant p53 temperature-sensitive DNA binding. |
| Q41134102 | Regulation of p53 in response to ionizing radiation in ataxia telangiectasia fibroblasts |
| Q39792211 | Replication of damaged DNA in vitro is blocked by p53. |
| Q35924458 | Repression of the basal c-fos promoter by wild-type p53 |
| Q41515342 | Role of p53 in apoptosis. |
| Q70484971 | Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE) |
| Q34055205 | Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes |
| Q39876425 | Simian virus 40 small t antigen activates the carboxyl-terminal transforming p53-binding domain of large T antigen. |
| Q38309561 | Stimulation of polyomavirus DNA replication by wild-type p53 through the DNA-binding site |
| Q47600672 | Structural basis for p53 binding-induced DNA bending |
| Q42590443 | Temperature sensitivity for conformation is an intrinsic property of wild-type p53. |
| Q40722479 | The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. |
| Q77753611 | The C-terminal domain of p53 catalyzes DNA-renaturation and strand exchange toward annealing between intact ssDNAs and toward eliminating damaged ssDNA from duplex formation through preferential recognition of damaged DNA by a duocarmycin |
| Q34350684 | The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms |
| Q39013660 | The Transactivation Domains of the p53 Protein |
| Q42809363 | The Tumor Suppressor p53 Regulates Its Own Transcription |
| Q40041446 | The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. |
| Q34252975 | The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity |
| Q28639955 | The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding |
| Q46189468 | The essential role of p53 in hyperpigmentation of the skin via regulation of paracrine melanogenic cytokine receptor signaling |
| Q24645732 | The first 30 years of p53: growing ever more complex |
| Q36423942 | The functional domains in p53 family proteins exhibit both common and distinct properties |
| Q40570055 | The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase |
| Q80387675 | The over-expression of p53 H179Y residue mutation causes the increase of cyclin A1 and Cdk4 expression in HELF cells |
| Q40961528 | The p53 gene and its role in human brain tumors. |
| Q36237614 | The p53 protein is an unusually shaped tetramer that binds directly to DNA. |
| Q37887629 | The p53 tumor suppressor protein regulates hematopoietic stem cell fate |
| Q28206425 | The processing of Holliday junctions by BLM and WRN helicases is regulated by p53 |
| Q38331206 | The role of DNA damage responses in p53 biology |
| Q73682108 | The role of p53 tumor suppressor gene and bcl-2 protooncogene in rat corpus luteum death |
| Q33807833 | The role of the E6-p53 interaction in the molecular pathogenesis of HPV. |
| Q34602545 | The significance of immunohistochemistry in the diagnosis and therapy of neoplasms |
| Q33938629 | The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein |
| Q73694178 | The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter |
| Q38042630 | Therapeutic strategies for head and neck cancer based on p53 status |
| Q34055161 | Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation. |
| Q42484376 | Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice |
| Q39005896 | Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. |
| Q36656119 | Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16 |
| Q72645717 | Transcriptional regulation by p53. Functional interactions among multiple regulatory domains |
| Q34616640 | Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein |
| Q36183682 | Tumor suppressor genes in the cell cycle |
| Q47948675 | Tumor suppressor genes: prospects for cancer therapies |
| Q34314048 | Tumor suppressor p53 mutations and breast cancer: a critical analysis |
| Q33807787 | Twenty years of p53 research: structural and functional aspects of the p53 protein |
| Q24336035 | Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression |
| Q40060664 | Two synthetic Sp1-binding sites functionally substitute for the 21-base-pair repeat region to activate simian virus 40 growth in CV-1 cells |
| Q38480106 | Ultraviolet Light Induces Expression of p53 and p21 in Human Skin: Effect of Sunscreen and Constitutive p21 Expression in Skin Appendages |
| Q41301503 | Wild-Type p53 Regulates Its Own Transcription in a Cell-Type Specific Manner |
| Q37637234 | Wild-type alternatively spliced p53: binding to DNA and interaction with the major p53 protein in vitro and in cells. |
| Q38288588 | Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter |
| Q59054260 | Wild-type p53 activates transcription in vitro |
| Q40872252 | Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA. |
| Q24300991 | Wild-type p53 binds to the TATA-binding protein and represses transcription |
| Q81554284 | Wild-type p53 stimulates homologous recombination upon sequence-specific binding to the ribosomal gene cluster repeat |
| Q29618316 | mdm2 expression is induced by wild type p53 activity |
| Q71170481 | p53 Protein exhibits 3'-to-5' exonuclease activity |
| Q55239676 | p53 antisense oligonucleotide inhibits growth of human colon tumor and normal cell lines. |
| Q33888115 | p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53 |
| Q34972350 | p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. |
| Q40392809 | p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain |
| Q58796385 | p53 domains: suppression, transformation, and transactivation |
| Q37619644 | p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression. |
| Q34146568 | p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine |
| Q40017706 | p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner |
| Q42645736 | p53 is a general repressor of RNA polymerase III transcription |
| Q41595909 | p53 is covalently linked to 5.8S rRNA. |
| Q83855448 | p53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels |
| Q36373753 | p53 mutations increase resistance to ionizing radiation |
| Q28639938 | p53 oligomerization and DNA looping are linked with transcriptional activation |
| Q34618968 | p53 regulates the minimal promoter of the human topoisomerase IIalpha gene |
| Q36618282 | p53 status of newly established acute myeloid leukaemia cell lines |
| Q41197877 | p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells |
| Q41640484 | p53 tumor-suppressor gene: clues to molecular carcinogenesis |
| Q37370175 | p53-Induced DNA bending: the interplay between p53-DNA and p53-p53 interactions |
| Q40873109 | p53-catalyzed annealing of complementary single-stranded nucleic acids |
| Q33937620 | p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer |
| Q40688905 | p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha |
| Q41033703 | pZ402, an improved SV40-based shuttle vector containing a T-antigen mutant unable to interact with wild-type p53. |
Search more.